Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hoh, Rebecca
NCT04648046: CAR-T Cells for HIV Infection	Recruiting	1/2	18	US	Cyclophosphamide, LVgp120duoCAR-T cells, low dose, LVgp120duoCAR-T cells, high dose, Analytic Treatment Interruption	Steven Deeks, Caring Cross	HIV Infections	12/27	12/28
SCOPE-ATI, NCT04359186: SCOPE Analytic Treatment Interruption Protocol	Recruiting	N/A	40	US	Treatment Interruption Arm	University of California, San Francisco, Chan Zuckerberg Biohub	HIV/AIDS	06/25	06/26
LIINC, NCT04362150: Long-term Impact of Infection With Novel Coronavirus (COVID-19)	Recruiting	N/A	800	US		University of California, San Francisco	COVID	12/25	12/25
NCT00187512: SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era	Recruiting	N/A	2500	US		University of California, San Francisco, National Institute of Allergy and Infectious Diseases (NIAID)	HIV Infections	12/32	12/33